193 related articles for article (PubMed ID: 15842957)
1. Genetically engineered vaccines.
Thomas WR; Hales BJ; Smith WA
Curr Allergy Asthma Rep; 2005 May; 5(3):197-203. PubMed ID: 15842957
[TBL] [Abstract][Full Text] [Related]
2. Analysis of epitope-specific immune responses induced by vaccination with structurally folded and unfolded recombinant Bet v 1 allergen derivatives in man.
Pree I; Reisinger J; Focke M; Vrtala S; Pauli G; van Hage M; Cromwell O; Gadermaier E; Egger C; Reider N; Horak F; Valenta R; Niederberger V
J Immunol; 2007 Oct; 179(8):5309-16. PubMed ID: 17911617
[TBL] [Abstract][Full Text] [Related]
3. Dissection of immunoglobulin E and T lymphocyte reactivity of isoforms of the major birch pollen allergen Bet v 1: potential use of hypoallergenic isoforms for immunotherapy.
Ferreira F; Hirtenlehner K; Jilek A; Godnik-Cvar J; Breiteneder H; Grimm R; Hoffmann-Sommergruber K; Scheiner O; Kraft D; Breitenbach M; Rheinberger HJ; Ebner C
J Exp Med; 1996 Feb; 183(2):599-609. PubMed ID: 8627171
[TBL] [Abstract][Full Text] [Related]
4. Pollen-related food allergy: cloning and immunological analysis of isoforms and mutants of Mal d 1, the major apple allergen, and Bet v 1, the major birch pollen allergen.
Son DY; Scheurer S; Hoffmann A; Haustein D; Vieths S
Eur J Nutr; 1999 Aug; 38(4):201-15. PubMed ID: 10502033
[TBL] [Abstract][Full Text] [Related]
5. Allergy vaccine engineering: epitope modulation of recombinant Bet v 1 reduces IgE binding but retains protein folding pattern for induction of protective blocking-antibody responses.
Holm J; Gajhede M; Ferreras M; Henriksen A; Ipsen H; Larsen JN; Lund L; Jacobi H; Millner A; Würtzen PA; Spangfort MD
J Immunol; 2004 Oct; 173(8):5258-67. PubMed ID: 15470071
[TBL] [Abstract][Full Text] [Related]
6. A nonallergenic birch pollen allergy vaccine consisting of hepatitis PreS-fused Bet v 1 peptides focuses blocking IgG toward IgE epitopes and shifts immune responses to a tolerogenic and Th1 phenotype.
Marth K; Breyer I; Focke-Tejkl M; Blatt K; Shamji MH; Layhadi J; Gieras A; Swoboda I; Zafred D; Keller W; Valent P; Durham SR; Valenta R
J Immunol; 2013 Apr; 190(7):3068-78. PubMed ID: 23440415
[TBL] [Abstract][Full Text] [Related]
7. Vaccines for birch pollen allergy based on genetically engineered hypoallergenic derivatives of the major birch pollen allergen, Bet v 1.
Mahler V; Vrtala S; Kuss O; Diepgen TL; Suck R; Cromwell O; Fiebig H; Hartl A; Thalhamer J; Schuler G; Kraft D; Valenta R
Clin Exp Allergy; 2004 Jan; 34(1):115-22. PubMed ID: 14720271
[TBL] [Abstract][Full Text] [Related]
8.
Aglas L; Bethanis A; Chrusciel P; Stolz F; Gruen M; Jaakkola UM; Jongejan L; Yatkin E; Van Ree R
Front Immunol; 2020; 11():2118. PubMed ID: 33013894
[TBL] [Abstract][Full Text] [Related]
9. Modified recombinant allergens for safer immunotherapy.
Ferreira F; Briza P; Inführ D; Schmidt G; Wallner M; Wopfner N; Thalhamer J; Achatz G
Inflamm Allergy Drug Targets; 2006 Jan; 5(1):5-14. PubMed ID: 16613559
[TBL] [Abstract][Full Text] [Related]
10. Immunization with Hypoallergens of shrimp allergen tropomyosin inhibits shrimp tropomyosin specific IgE reactivity.
Wai CY; Leung NY; Ho MH; Gershwin LJ; Shu SA; Leung PS; Chu KH
PLoS One; 2014; 9(11):e111649. PubMed ID: 25365343
[TBL] [Abstract][Full Text] [Related]
11. Frequent occurrence of T cell-mediated late reactions revealed by atopy patch testing with hypoallergenic rBet v 1 fragments.
Campana R; Moritz K; Marth K; Neubauer A; Huber H; Henning R; Blatt K; Hoermann G; Brodie TM; Kaider A; Valent P; Sallusto F; Wöhrl S; Valenta R
J Allergy Clin Immunol; 2016 Feb; 137(2):601-609.e8. PubMed ID: 26518092
[TBL] [Abstract][Full Text] [Related]
12. Skin test evaluation of genetically engineered hypoallergenic derivatives of the major birch pollen allergen, Bet v 1: results obtained with a mix of two recombinant Bet v 1 fragments and recombinant Bet v 1 trimer in a Swedish population before the birch pollen season.
van Hage-Hamsten M; Kronqvist M; Zetterström O; Johansson E; Niederberger V; Vrtala S; Grönlund H; Grönneberg R; Valenta R
J Allergy Clin Immunol; 1999 Nov; 104(5):969-77. PubMed ID: 10550741
[TBL] [Abstract][Full Text] [Related]
13. Genetic engineering of allergens: future therapeutic products.
Ferreira F; Wallner M; Breiteneder H; Hartl A; Thalhamer J; Ebner C
Int Arch Allergy Immunol; 2002 Jul; 128(3):171-8. PubMed ID: 12119498
[TBL] [Abstract][Full Text] [Related]
14. T cell epitope-containing hypoallergenic recombinant fragments of the major birch pollen allergen, Bet v 1, induce blocking antibodies.
Vrtala S; Akdis CA; Budak F; Akdis M; Blaser K; Kraft D; Valenta R
J Immunol; 2000 Dec; 165(11):6653-9. PubMed ID: 11086111
[TBL] [Abstract][Full Text] [Related]
15. Development and characterization of a recombinant, hypoallergenic, peptide-based vaccine for grass pollen allergy.
Focke-Tejkl M; Weber M; Niespodziana K; Neubauer A; Huber H; Henning R; Stegfellner G; Maderegger B; Hauer M; Stolz F; Niederberger V; Marth K; Eckl-Dorna J; Weiss R; Thalhamer J; Blatt K; Valent P; Valenta R
J Allergy Clin Immunol; 2015 May; 135(5):1207-7.e1-11. PubMed ID: 25441634
[TBL] [Abstract][Full Text] [Related]
16. Recombinant allergens for immunotherapy.
Chapman MD; Smith AM; Vailes LD; Pomés A
Allergy Asthma Proc; 2002; 23(1):5-8. PubMed ID: 11894735
[TBL] [Abstract][Full Text] [Related]
17. Hypoallergenic Der p 1/Der p 2 combination vaccines for immunotherapy of house dust mite allergy.
Chen KW; Blatt K; Thomas WR; Swoboda I; Valent P; Valenta R; Vrtala S
J Allergy Clin Immunol; 2012 Aug; 130(2):435-43.e4. PubMed ID: 22789398
[TBL] [Abstract][Full Text] [Related]
18. Expression of an endotoxin-free S-layer/allergen fusion protein in gram-positive Bacillus subtilis 1012 for the potential application as vaccines for immunotherapy of atopic allergy.
Ilk N; Schumi CT; Bohle B; Egelseer EM; Sleytr UB
Microb Cell Fact; 2011 Feb; 10():6. PubMed ID: 21310062
[TBL] [Abstract][Full Text] [Related]
19. Molecular approaches for new vaccines against allergy.
Niederberger V; Valenta R
Expert Rev Vaccines; 2006 Feb; 5(1):103-10. PubMed ID: 16451112
[TBL] [Abstract][Full Text] [Related]
20. Prevention of birch pollen-related food allergy by mucosal treatment with multi-allergen-chimers in mice.
Hoflehner E; Hufnagl K; Schabussova I; Jasinska J; Hoffmann-Sommergruber K; Bohle B; Maizels RM; Wiedermann U
PLoS One; 2012; 7(6):e39409. PubMed ID: 22768077
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
